Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Dicker

Showing results (271-280 of 375) with videos related to

Pageof 38
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2017
Genomic Classifier Augments the Role of Pathological Features in Identifying Optimal Candidates for Adjuvant Radiation Therapy in Patients With Prostate Cancer: Development and Internal Validation of a Multivariable Prognostic ModelDeepansh Dalela, María Santiago-Jiménez, Kasra Yousefi, et al.
Breast Cancer Research and Treatment|July 20, 2018
Onco-metabolism: defining the prognostic significance of obesity and diabetes in women with brain metastases from breast cancerNeal S McCall, Brittany A Simone, Minesh Mehta, et al.
Brachytherapy|March 29, 2020
A phase IB clinical trial of 15 Gy HDR brachytherapy followed by hypofractionated/SBRT in the management of intermediate-risk prostate cancerRobert B Den, Jacob Greenspan, Laura A Doyle, et al.
Journal for Immunotherapy of Cancer|June 19, 2022
Longitudinal plasma proteomic profiling of patients with non-small cell lung cancer undergoing immune checkpoint blockadeMichal Harel, Coren Lahav, Eyal Jacob, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 19, 2010
Hypofractionated stereotactic radiation therapy: an effective therapy for recurrent high-grade gliomasShannon E Fogh, David W Andrews, Jon Glass, et al.
Journal of Neuro-Oncology|April 15, 2014
Vorinostat as a radiosensitizer for brain metastasis: a phase I clinical trialWenyin Shi, Yaacov Richard Lawrence, Hak Choy, et al.
American Journal of Clinical Oncology|February 28, 2015
Hematologic Toxicity of Concurrent Administration of Radium-223 and Next-generation Antiandrogen TherapiesTu D Dan, Harriet B Eldredge-Hindy, Jean Hoffman-Censits, et al.
International Journal of Radiation Oncology, Biology, Physics|August 9, 2014
A pilot study of hypofractionated stereotactic radiation therapy and sunitinib in previously irradiated patients with recurrent high-grade gliomaEvan J Wuthrick, Walter J Curran, Kevin Camphausen, et al.
Radiation Oncology (London, England)|December 29, 2012
Fractionated stereotactic radiation therapy improves cranial neuropathies in patients with skull base meningiomas: a retrospective cohort studyXinglei Shen, David W Andrews, Robert C Sergott, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 19, 2015
Novel actions of next-generation taxanes benefit advanced stages of prostate cancerRenée de Leeuw, Lisa D Berman-Booty, Matthew J Schiewer, et al.
Pageof 38

Showing results (271-280 of 375) with videos related to

Sort By:
Pageof 38
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2017
Genomic Classifier Augments the Role of Pathological Features in Identifying Optimal Candidates for Adjuvant Radiation Therapy in Patients With Prostate Cancer: Development and Internal Validation of a Multivariable Prognostic ModelDeepansh Dalela, María Santiago-Jiménez, Kasra Yousefi, et al.
Breast Cancer Research and Treatment|July 20, 2018
Onco-metabolism: defining the prognostic significance of obesity and diabetes in women with brain metastases from breast cancerNeal S McCall, Brittany A Simone, Minesh Mehta, et al.
Brachytherapy|March 29, 2020
A phase IB clinical trial of 15 Gy HDR brachytherapy followed by hypofractionated/SBRT in the management of intermediate-risk prostate cancerRobert B Den, Jacob Greenspan, Laura A Doyle, et al.
Journal for Immunotherapy of Cancer|June 19, 2022
Longitudinal plasma proteomic profiling of patients with non-small cell lung cancer undergoing immune checkpoint blockadeMichal Harel, Coren Lahav, Eyal Jacob, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 19, 2010
Hypofractionated stereotactic radiation therapy: an effective therapy for recurrent high-grade gliomasShannon E Fogh, David W Andrews, Jon Glass, et al.
Journal of Neuro-Oncology|April 15, 2014
Vorinostat as a radiosensitizer for brain metastasis: a phase I clinical trialWenyin Shi, Yaacov Richard Lawrence, Hak Choy, et al.
American Journal of Clinical Oncology|February 28, 2015
Hematologic Toxicity of Concurrent Administration of Radium-223 and Next-generation Antiandrogen TherapiesTu D Dan, Harriet B Eldredge-Hindy, Jean Hoffman-Censits, et al.
International Journal of Radiation Oncology, Biology, Physics|August 9, 2014
A pilot study of hypofractionated stereotactic radiation therapy and sunitinib in previously irradiated patients with recurrent high-grade gliomaEvan J Wuthrick, Walter J Curran, Kevin Camphausen, et al.
Radiation Oncology (London, England)|December 29, 2012
Fractionated stereotactic radiation therapy improves cranial neuropathies in patients with skull base meningiomas: a retrospective cohort studyXinglei Shen, David W Andrews, Robert C Sergott, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 19, 2015
Novel actions of next-generation taxanes benefit advanced stages of prostate cancerRenée de Leeuw, Lisa D Berman-Booty, Matthew J Schiewer, et al.
Pageof 38